NCT00858988View on ClinicalTrials.gov

Trial of Rifaximin in the Treatment of Tropical Enteropathy

NACompletedINTERVENTIONAL
Enrollment

147

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions
Tropical Enteropathy
Interventions
DRUG

Rifaximin

100mg of rifaxin for 7 consecutive days, twice daily

DRUG

Placebo

twice daily for 7 consecutive days

Trial Locations (1)

Unknown

Limela

All Listed Sponsors
collaborator

Baylor College of Medicine

OTHER

collaborator

Kamuzu University of Health Sciences

OTHER

collaborator

United States Department of Agriculture (USDA)

FED

lead

Washington University School of Medicine

OTHER

NCT00858988 - Trial of Rifaximin in the Treatment of Tropical Enteropathy | Biotech Hunter | Biotech Hunter